Our team comprises of accomplished scientist-entrepreneurs with novel foresight to imagine innovative solutions and products.

Dr. Kimberly Negrin is the Founder of Bloom Bio, a boutique consultancy specializing in technology advisory, commercialization strategy, fractional leadership, and executive coaching for life science companies. She is an accomplished strategy and business operations leader in the cell and gene therapy (CGT) industry. Her approach uniquely
Dr. Kimberly Negrin is the Founder of Bloom Bio, a boutique consultancy specializing in technology advisory, commercialization strategy, fractional leadership, and executive coaching for life science companies. She is an accomplished strategy and business operations leader in the cell and gene therapy (CGT) industry. Her approach uniquely blends deep scientific expertise with practical business acumen, enabling early-stage and growth-stage innovators to accelerate their impact.
Previously, Dr. Negrin was a Senior Vice President of Commercial at Nucleus Biologics and played a leadership role for HemaCare (a Charles River company) overseeing and supporting clients as they mature through research, clinical, and commercial development of novel engineered and manufactured cell therapy products and applications. She previously worked at Agilent Technologies and Seahorse Bioscience.
Kimberly earned her PhD in Biomedical Science from the University of Massachusetts Medical School, where her research focused on immunometabolism and lipid-based delivery systems, including liposome protocols foundational to today’s lipid nanoparticle technologies.